Suchergebnisse - "Jones, Jefferson M"

PubPharm (78)

1

Use of U.S. Blood Donors for National Serosurveillance of SARS-CoV-2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program

enthalten in: bioRxiv.org | 2024

von Stone, M. | Germanio, C. | Wright, D. | +16

2

Administration of the GSK Respiratory Syncytial Virus Vaccine to Pregnant Persons in Error

enthalten in: Obstetrics and gynecology | 2024

von Moro, P. | Gallego, R. | Scheffey, A. | +7

3

Long-Term Symptoms Associated With SARS-CoV-2 Infection Among Blood Donors

enthalten in: JAMA network open | 2024

von Shah, M. | Spencer, B. | James-Gist, J. | +5

4

Hybrid immunity and SARS-CoV-2 antibodies : results of the HEROES-RECOVER prospective cohort study

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Romine, J. | Li, H. | Coughlin, M. | +27

5

Association Between Social Vulnerability and SARS-CoV-2 Seroprevalence in Specimens Collected From Commercial Laboratories, United States, September 2021-February 2022

enthalten in: Public health reports (Washington, D.C. : 1974) | 2024

von Benoit, T. | Kim, Y. | Deng, Y. | +7

6

What U.S. Obstetricians Need to Know About Respiratory Syncytial Virus

enthalten in: Obstetrics and gynecology | 2024

von Debessai, H. | Jones, J. | Meaney-Delman, D. | +1

7

Associations of Temporal Cardiometabolic Patterns and Incident SARS-CoV-2 Infection Among U.S. Blood Donors With Serologic Evidence of Vaccination

enthalten in: AJPM focus | 2024

von Yu, E. | Stone, M. | Bravo, M. | +8

8

Who Gets Sick From COVID-19? Sociodemographic Correlates of Severe Adult Health Outcomes During Alpha- and Delta-Variant Predominant Periods : September 2020-November 2021

enthalten in: The Journal of infectious diseases | 2024

von Wei, S. | Freeman, D. | Himschoot, A. | +17

9

Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants : Recommendations of the Advisory Committee on Immunization Practices - United States, 2023

enthalten in: MMWR. Morbidity and mortality weekly report | 2023

von Fleming-Dutra, K. | Jones, J. | Roper, L. | +13

10

Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children : Recommendations of the Advisory Committee on Immunization Practices - United States, 2023

enthalten in: MMWR. Morbidity and mortality weekly report | 2023

von Jones, J. | Fleming-Dutra, K. | Prill, M. | +8

1
2
3
4
5
6
7
8
Nächster »
[8]